Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
Melania Gaggini, Fabrizia Carli, Chiara Rosso, et al.
Hepatology (2017) Vol. 67, Iss. 1, pp. 145-158
Open Access | Times Cited: 386

Showing 1-25 of 386 citing articles:

The role of the microbiome in NAFLD and NASH
Aleksandra A. Kolodziejczyk, Danping Zheng, Oren Shibolet, et al.
EMBO Molecular Medicine (2018) Vol. 11, Iss. 2
Open Access | Times Cited: 444
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Mojgan Masoodi, Amalia Gastaldelli, Tuulia Hyötyläinen, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 12, pp. 835-856
Closed Access | Times Cited: 314
Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases
Anaïs Alves, Arthur Bassot, Anne‐Laure Bulteau, et al.
Nutrients (2019) Vol. 11, Iss. 6, pp. 1356-1356
Open Access | Times Cited: 275
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Jiezhong Chen, Luis Vitetta
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5214-5214
Open Access | Times Cited: 236
Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis
Santosh Kumar, Qihua Duan, Rongxue Wu, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113869-113869
Closed Access | Times Cited: 222
NASH in Lean Individuals
Ramy Younes, Elisabetta Bugianesi
Seminars in Liver Disease (2019) Vol. 39, Iss. 01, pp. 086-095
Open Access | Times Cited: 212
Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome
Oren Rom, Yuhao Liu, Zhipeng Liu, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 572
Open Access | Times Cited: 201
Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach
Ran Jin, Rob McConnell, Catherine E. Cioffi, et al.
Environment International (2019) Vol. 134, pp. 105220-105220
Open Access | Times Cited: 175
The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology
Aikaterini Dimou, Vasilis Tsimihodimos, Eleni Bairaktari
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 4022-4022
Open Access | Times Cited: 99
Insulin-regulated serine and lipid metabolism drive peripheral neuropathy
Michal K. Handzlik, Jivani M. Gengatharan, Katie Frizzi, et al.
Nature (2023) Vol. 614, Iss. 7946, pp. 118-124
Open Access | Times Cited: 97
Gut microbiota: A new target for T2DM prevention and treatment
Lulu Liu, Jiheng Zhang, Yi Cheng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 92
Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway
Li-Shan Yan, Shuofeng Zhang, Gan Luo, et al.
Metabolism (2022) Vol. 131, pp. 155200-155200
Closed Access | Times Cited: 91
Risk assessment with gut microbiome and metabolite markers in NAFLD development
Howell Leung, Xiaoxue Long, Yueqiong Ni, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 648
Open Access | Times Cited: 79
Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations
Yueqiong Ni, Lingling Qian, Sara Leal Siliceo, et al.
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1530-1547.e8
Open Access | Times Cited: 73
Glycine: The Smallest Anti-Inflammatory Micronutrient
Karla Aidee Aguayo-Cerón, Fausto Sánchez‐Muñoz, Rocío Alejandra Gutiérrez-Rojas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11236-11236
Open Access | Times Cited: 48
Hepatic glucose metabolism in the steatotic liver
Egeria Scoditti, Silvia Sabatini, Fabrizia Carli, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 5, pp. 319-334
Closed Access | Times Cited: 32
In Vivo Tissue Distribution of Polystyrene or Mixed Polymer Microspheres and Metabolomic Analysis after Oral Exposure in Mice
Marcus Garcia, Aaron S. Romero, Seth D. Merkley, et al.
Environmental Health Perspectives (2024) Vol. 132, Iss. 4
Open Access | Times Cited: 25
Tea Polyphenol Epigallocatechin Gallate Protects Against Nonalcoholic Fatty Liver Disease and Associated Endotoxemia in Rats via Modulating Gut Microbiota Dysbiosis and Alleviating Intestinal Barrier Dysfunction and Related Inflammation
Gaolong Zuo, Meiyan Chen, Yingpeng Zuo, et al.
Journal of Agricultural and Food Chemistry (2024)
Closed Access | Times Cited: 18
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Maja Thiele, Ida Falk Villesen, Lili Niu, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 345-359
Open Access | Times Cited: 16
Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non‐alcoholic fatty liver disease
Weijun Wang, Jinfang Zhao, Wenfang Gui, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 3, pp. 469-484
Open Access | Times Cited: 154
Metabolic liver disease in diabetes – From mechanisms to clinical trials
Bedair Dewidar, S. Kahl, Kalliopi Pafili, et al.
Metabolism (2020) Vol. 111, pp. 154299-154299
Open Access | Times Cited: 133
Prenatal Exposure to Perfluoroalkyl Substances Associated With Increased Susceptibility to Liver Injury in Children
Nikos Stratakis, David V. Conti, Ran Jin, et al.
Hepatology (2020) Vol. 72, Iss. 5, pp. 1758-1770
Open Access | Times Cited: 133
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
Anne Fougerat, Alexandra Montagner, Nicolas Loiseau, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1638-1638
Open Access | Times Cited: 114
Coordinated Modulation of Energy Metabolism and Inflammation by Branched-Chain Amino Acids and Fatty Acids
Zhenhong Ye, Siyu Wang, Chunmei Zhang, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 112
Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis
Marie Winther‐Sørensen, Katrine D. Galsgaard, Alberto Santos, et al.
Molecular Metabolism (2020) Vol. 42, pp. 101080-101080
Open Access | Times Cited: 90
Page 1 - Next Page

Scroll to top